142 related articles for article (PubMed ID: 34918677)
1. Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy.
Wu Q; Li F; Yin X; Gao J; Zhang X
Medicine (Baltimore); 2021 Dec; 100(50):e28196. PubMed ID: 34918677
[TBL] [Abstract][Full Text] [Related]
2. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
3. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
[TBL] [Abstract][Full Text] [Related]
4. Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme.
Nomura M; Ito K; Miyakubo M; Sekine Y; Tamura Y; Shimizu N; Aoki S; Suzuki K
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):202-9. PubMed ID: 22143446
[TBL] [Abstract][Full Text] [Related]
5. The potential of a nomogram combined PI-RADS v2.1 and contrast-enhanced ultrasound (CEUS) to reduce unnecessary biopsies in prostate cancer diagnostics.
Liu Y; Wang S; Xiang LH; Xu G; Dong L; Sun Y; Ye B; Zhang Y; Xu H
Br J Radiol; 2022 Sep; 95(1138):20220209. PubMed ID: 35877385
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a nomogram including lymphocyte-to-monocyte ratio for initial prostate biopsy: a double-center retrospective study.
Zhou ZH; Liu F; Wang WJ; Liu X; Sun LJ; Zhu Y; Ye DW; Zhang GM
Asian J Androl; 2021; 23(1):41-46. PubMed ID: 32503957
[TBL] [Abstract][Full Text] [Related]
7. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
Lee A; Lim J; Gao X; Liu L; Chia SJ
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
[TBL] [Abstract][Full Text] [Related]
8. A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy.
Sun J; Zhang Z; OuYang J
Urol Oncol; 2020 May; 38(5):401-409. PubMed ID: 31870724
[TBL] [Abstract][Full Text] [Related]
9. Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy.
Lughezzani G; Lazzeri M; Haese A; McNicholas T; de la Taille A; Buffi NM; Fossati N; Lista G; Larcher A; Abrate A; Mistretta A; Bini V; Palou Redorta J; Graefen M; Guazzoni G
Eur Urol; 2014 Nov; 66(5):906-12. PubMed ID: 24361258
[TBL] [Abstract][Full Text] [Related]
10. The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL.
Shen P; Zhao J; Sun G; Chen N; Zhang X; Gui H; Yang Y; Liu J; Shu K; Wang Z; Zeng H
Andrology; 2017 May; 5(3):548-555. PubMed ID: 28409907
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
Karakiewicz PI; Benayoun S; Kattan MW; Perrotte P; Valiquette L; Scardino PT; Cagiannos I; Heinzer H; Tanguay S; Aprikian AG; Huland H; Graefen M
J Urol; 2005 Jun; 173(6):1930-4. PubMed ID: 15879784
[TBL] [Abstract][Full Text] [Related]
12. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
Zaytoun OM; Kattan MW; Moussa AS; Li J; Yu C; Jones JS
Urology; 2011 Aug; 78(2):392-8. PubMed ID: 21705045
[TBL] [Abstract][Full Text] [Related]
13. Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
Hansen J; Auprich M; Ahyai SA; de la Taille A; van Poppel H; Marberger M; Stenzl A; Mulders PF; Huland H; Fisch M; Abbou CC; Schalken JA; Fradet Y; Marks LS; Ellis W; Partin AW; Pummer K; Graefen M; Haese A; Walz J; Briganti A; Shariat SF; Chun FK
Eur Urol; 2013 Feb; 63(2):201-9. PubMed ID: 22854248
[TBL] [Abstract][Full Text] [Related]
14. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume.
Remzi M; Fong YK; Dobrovits M; Anagnostou T; Seitz C; Waldert M; Harik M; Marihart S; Marberger M; Djavan B
J Urol; 2005 Oct; 174(4 Pt 1):1256-60; discussion 1260-1; author reply 1261. PubMed ID: 16145388
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.
Gayet M; Mannaerts CK; Nieboer D; Beerlage HP; Wijkstra H; Mulders PFA; Roobol MJ
Eur Urol Focus; 2018 Mar; 4(2):228-234. PubMed ID: 28753781
[TBL] [Abstract][Full Text] [Related]
16. Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancer.
Feng F; Zhong YX; Chen Y; Lin FX; Huang JH; Mai Y; Zhao PP; Wei W; Zhu HC; Xu ZP
BMC Urol; 2023 Jul; 23(1):120. PubMed ID: 37452418
[TBL] [Abstract][Full Text] [Related]
17. Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.
Nowroozi MR; Amini S; Kasaeian A; Zavarehei MJ; Eshraghian MR; Ayati M
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e289-97. PubMed ID: 24684767
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of a nomogram for predicting positive repeat prostate biopsy in Chinese men].
Li QY; Tang J; Li YM; Fei X; Zhang Y; He EH; Zhou Y
Zhonghua Nan Ke Xue; 2012 Apr; 18(4):302-5. PubMed ID: 22574362
[TBL] [Abstract][Full Text] [Related]
19. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region.
Zhou Z; Liang Z; Zuo Y; Zhou Y; Yan W; Wu X; Ji Z; Li H; Hu M; Ma L
Prostate; 2022 Apr; 82(5):556-565. PubMed ID: 35098557
[TBL] [Abstract][Full Text] [Related]
20. The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL.
Ng CF; Chiu PK; Lam NY; Lam HC; Lee KW; Hou SS
Int Urol Nephrol; 2014 Apr; 46(4):711-7. PubMed ID: 24136184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
